Johnson & Johnson

JNJ

NYSEBiotechnology🇺🇸North America

Drugs in Pipeline

Phase 3 Programs

Upcoming Catalysts

Next Catalyst

Jun 30, 2026

Drug Pipeline

Drug Name	Phase	Indication	Designations
Paliperidone palmitate	Phase 3	Schizophrenia	-
tapentadol (CG5503) ER	Phase 3	Low Back Pain	-
norelgestromin + ethinyl estradiol; mercilon	Phase 3	Contraception	-
Extended-release galantamine hydrobromide	Phase 3	Schizophrenia	-
acetaminophen	Phase 3	Osteoarthritis of the Knee	-
Olanzapine	Phase 3	Bipolar Disorder	-
Risperidone, oral tablets	Phase 3	Bipolar Disorders	-
Test naproxen sodium tablet	Phase 3	Post-operative Dental Pain	-
Topiramate; Placebo	Phase 3	Migraine	-
galantamine	Phase 3	Alzheimer's Disease	-
5% Minoxidil Topical Foam	Phase 3	Androgenetic Alopecia	-
paliperidone ER tablets, quetiapine tablets, placebo - all over encapsulated	Phase 3	Schizophrenia	-
rabeprazole	Phase 3	Gastroesophageal Reflux Disease (GERD)	-
galantamine hydrobromide	Phase 3	Alzheimer Disease	-
Hydromorphone HCl	Phase 3	Pain	-
topiramate, phenytoin	Phase 3	Epilepsy	-
CG 5503;tapentadol	Phase 3	Osteoarthritis	-
levofloxacin	Phase 3	Pneumonia	-
Rivaroxaban	Phase 3	Atrial Fibrillation	-
tapentadol (CG5503) Immediate Release IR	Phase 3	Low Back Pain	-
levofloxacin, azithromycin, amoxicillin/clavulanate	Phase 3	Bronchitis	-
Acetaminophen/Naproxen Sodium Fixed Combination	Phase 3	Pain	-
Bortezomib	Phase 3	Multiple Myeloma	-
Paliperidone extended-release	Phase 3	Bipolar Disorder	-
Risperdal Consta	Phase 3	Bipolar Disorder	-
Vincristine, DOXIL (doxorubicin HCl liposomal injection), and Dexamethasone (VDD) vs. Vincristine, Doxorubicin and Dexamethasone (VAD)	Phase 3	Multiple Myeloma	-
paliperidone ER Oros	Phase 3	Schizophrenia	-
Mebendazole	Phase 3	Healthy Volunteers	-
Dapoxetine	Phase 3	Erectile Dysfunction	-
levofloxacin; amoxicillin/clavulanate	Phase 3	Otitis Media	-
Paliperidone ER	Phase 3	Schizophrenia	-
topiramate	Phase 3	Essential Tremor	-
Placebo	Phase 3	Bipolar Disorder	-
doripenem	Phase 3	Pneumonia	-
Trabectedin	Phase 3	Ovarian Cancer	-
risperidone	Phase 3	Bipolar Disorders	-
norelgestromin + ethinyl estradiol	Phase 3	Contraception	-
Rabeprazole sodium 5 mg	Phase 3	Gastroesophageal Reflux	-
Paliperidone palmitate 25 mg eq.	Phase 3	Schizophrenia	-
JNJ-90301900 (NBTXR3)	Phase 3	Locally Advanced Head and Neck Squamous Cell Carcinoma	-
JNJ-90301900	Phase 2	Carcinoma, Non-Small-Cell Lung	-
Experimental Product 1% Colloidal Oatmeal Balm	Phase 2	Atopic Dermatitis	-
tapentadol HCl	Phase 2	Pain	-
epoetin alfa	Phase 2	Chronic Kidney Disease	-
JNJ16269110	Phase 2	Diabetes Mellitus, Type 2	-
Dexamethasone	Phase 2	Endometrial Neoplasms	-
ibuprofen; pseudoephedrine HCl	Phase 2	Enuresis	-
JNJ-17166864	Phase 2	Allergic Rhinitis	-
Decitabine	Phase 2	Myelodysplastic Syndrome	-
JNJ-37822681	Phase 2	Schizophrenia	-
Acetaminophen (ACE) (1000 mg)	Phase 2	Dental Pain	-
R256918	Phase 2	Obesity	-
PROCRIT (Epoetin alfa)	Phase 2	Anemia	-
R092670	Phase 2	Schizophrenia	-
ZARNESTRA, tipifarnib, R115777	Phase 2	Acute Myeloid Leukemia	-

Catalyst Timeline

1 upcoming, 0 past

⭐Phase 3Next

JNJ-90301900 (NBTXR3) Phase 3 Results Expected

Jun 30, 2026JNJ-90301900 (NBTXR3)

Primary completion for JNJ-90301900 (NBTXR3) trial (NCT04892173) in Locally Advanced Head and Neck Squamous Cell Carcinoma

Source

Regulatory Approvals

JNJ News